Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2023-11-08 Call Transcript
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of a conference call discussing the financial results for Q2 and H1 FY24 of Dr. Lal PathLabs Limited. It includes management speeches, financial highlights, business trends, and Q&A participation details. The presence of detailed financial data, management commentary, and the format of a conference call transcript clearly identifies this as a Call Transcript (CT). The document is not a brief announcement or a report publication notice, but a full transcript of the earnings call, meeting the criteria for the CT category.
2023-11-08 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the publication of the company's financial results for the quarter and half year ended September 30, 2023. It references Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that a newspaper advertisement of the financial results has been published. The document itself does not contain detailed financial statements or substantive financial data but rather serves as a notification or announcement that the financial results have been published in newspapers. The document length is about 15,000 characters, but the content is primarily an announcement of the publication of financial results, not the results themselves. According to the "Menu vs Meal" rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2023-11-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated November 2, 2023, informing about the availability of the audio recording of a conference call with investors and analysts for Q2 & H1 FY24. It references the SEBI regulations and provides a link to the recording on the company's website. The text does not contain the transcript itself, financial data, or detailed analysis, but merely announces the availability of the conference call recording. According to the rules, such announcements about conference call recordings are classified as Call Transcript (CT) if the transcript is included, but since this is only an announcement of the recording availability and not the transcript itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement. The document length is short (1455 characters), supporting that it is an announcement rather than the full transcript or report.
2023-11-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (1744 characters) informing the stock exchanges about the schedule of an upcoming analyst/institutional investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of a meeting schedule, not a report or transcript of the meeting itself. It does not contain financial data, management discussion, or detailed presentation materials. Therefore, it fits the category of an Investor Presentation announcement or meeting schedule notice. Given the definitions, the best fit is 'Investor Presentation' (IP) as it relates to investor meetings and presentations, even though this is a schedule notice rather than the presentation itself. However, since it is only a schedule notice and not the presentation content, and the document is short, it aligns more closely with Regulatory Filings (RNS) as a general regulatory announcement about investor meetings. The document does not meet criteria for other categories like Call Transcript or Annual Report. Hence, the classification is Regulatory Filings (RNS) with high confidence.
2023-11-02 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated November 2, 2023, announcing the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2023. It includes key financial highlights such as revenue, EBITDA, PAT margins, and EPS for Q2 FY 2023-24 compared to Q2 FY 2022-23. The document is titled as a press release and contains summary financial data but does not include full financial statements or detailed analysis typical of an Interim/Quarterly Report. The document is also relatively short (5356 characters) and serves as an initial announcement of quarterly financial results. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only. Q2 2024
2023-11-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is titled as an "Earnings Presentation on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2023." It includes detailed financial data such as revenue, EBITDA, PAT, margins, and EPS for Q2 FY24 and half-year FY24, along with operating highlights and management commentary. The document is approximately 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The content is consistent with a detailed investor presentation focusing on quarterly financial results and business updates. Therefore, the document fits the category of an Investor Presentation (IP) rather than a brief Earnings Release (ER) or a full Interim Report (IR), as it is a presentation format intended for analysts and investors with detailed financial and operational information.
2023-11-02 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.